Principal Investigator, Engineering high fidelity mutations to increase safety of live-attenuated alphavirus vaccines , (Principal Investigator), NIH NIAID
Co-Investigator, Characterization of blood transfusion-transmission of Zika virus in macaques, Mike Busch, Blood Systems Research Institute/UCSF (Principal Investigator), NIH NHLBI extension of Recipient Epidemiology and Donor Evaluation Study-III
Co-Investigator, Macaque model of Zika virus infection, Koen Van Rompay (Principal Investigator), NIH NIAID
Co-Investigator, Pacific Southwest Regional Center of Excellence for Vector-Borne Disease Research at the University of California, Chris Barker, PMI, William Walton, UC Riverside (Principal Investigator), Centers for Disease Control Regional Centers of Excellence
Co-Principal Investigator, Chikungunya virus like particle vaccine development: non-human primate studies to establish correlates of protection, Koen Van Rompay, California National Primate Research Center (Principal Investigator), FDA via PaxVax, Inc.
Co-Investigator, Cognitive, affective, and social development following fetal Zika virus infection of rhesus macaques. Percentile: 4, Eliza-Bliss Moreau, UC Davis (Principal Investigator), NIH NICHD
Principal Investigator, Viral molecular determinants of pathogenic mosquito-borne virus emergence: Usutu virus in Europe and St. Louis encephalitis virus in California, (Principal Investigator), Zoetis UCD2
Principal Investigator, Influenza A virus surveillance in avians and marine mammals in California, (Principal Investigator), NIH NIAID Center for Excellence in Influenza Virus Research